There are many different heart condition treatments on the market. Some of these have been around for many, many years, while others are relatively new. It is worth noting that insurers rarely refuse to pay for a treatment—no matter how new it is—unless the treatment is expensive. In 2019, the FDA approved tafamidis, sold under the brand name Vyndamax.